Skip to main content

Table 2 Comparison of the TBM group before and after anti-tuberculosis treatment

From: NELL2 as a potential marker of outcome in the cerebrospinal fluid of patients with tuberculous meningitis: preliminary results from a single-center observational study

 

Leukocyte (× 106/L)

Chloride (mmol/L)

Glucose (mmol/L)

LDH (U/L)

Protein (g/L)

Before therapy

450.00 ± 94.17

110.28 ± 10.79

1.58 ± 0.85

80.90 ± 50.31

2.13 ± 1.30

Treatment for 3 days

314.00 ± 296.60

112.88 ± 10.56

1.73 ± 1.20

83.05 ± 62.05

1.78 ± 1.08

Treatment for 7 days

205.50 ± 190.09

118.30 ± 8.39

1.60 ± 0.80

67.40 ± 69.18

1.27 ± 0.95

Treatment for 11 days

148.75 ± 161.26

118.45 ± 4.94

1.63 ± 0.88

38.58 ± 28.66

0.92 ± 0.54

Treatment for 16 days

122.00 ± 135.23

122.00 ± 3.90

1.75 ± 0.99

26.70 ± 16.87

0.81 ± 0.44

F value

5.115

6.830

0.234

4.637

6.922

P value

0.084

0.047

0.764

0.098

0.063